Biotech | January 04, 2022
Yokogawa invests in glycan production company GlyTech
Partnering to build biosynthesis processes and a pharmaceutical production platform
Partnering to build biosynthesis processes and a pharmaceutical production platform
The Health ID will allow users to connect with different healthcare providers and enable a consent-based sharing of personal health records
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age
The newly launched centre in Mumbai is part of the company’s ambition to be present in 100 cities across the country within two years.”
Zeebon is the largest diagnostics services provider in North-Eastern states
The company has developed the API in house at its R&D center in Hyderabad
The authorization provides an additional treatment option against the Covid-19 virus in the form of a pill that can be taken orally
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19
Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters
Subscribe To Our Newsletter & Stay Updated
